Pidus Tablet 15 mg contains Pioglitazone, an oral antidiabetic medication belonging to the class of thiazolidinediones (TZDs). It is used to improve blood sugar control in adults with type 2 diabetes mellitus by enhancing the body’s response to insulin. Unlike insulin or insulin secretagogues, Pioglitazone does not directly increase insulin secretion, but works by improving insulin sensitivity in muscle, fat, and liver tissues, thereby lowering blood glucose levels.
Pidus Tablet 15 mg is typically prescribed as part of a comprehensive diabetes management plan, which includes diet, exercise, and lifestyle modifications. It can be used alone or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin, depending on the patient’s glycemic profile.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Improves insulin sensitivity in the liver, muscle, and fat tissues
Helps lower fasting and postprandial blood glucose levels
Can be used alone or in combination with other antidiabetic medications
Supports long-term glycemic control in type 2 diabetes mellitus
Reduces the risk of diabetes-related complications when combined with lifestyle measures
Oral tablet formulation allows convenient once-daily dosing
Pioglitazone, the active ingredient in Pidus Tablet, works primarily through activation of peroxisome proliferator-activated receptor gamma (PPAR-γ):
Enhancement of Insulin Sensitivity:
Activation of PPAR-γ in adipose tissue, liver, and skeletal muscle increases glucose uptake and reduces hepatic glucose output.
This improves overall insulin sensitivity, helping the body use insulin more effectively.
Reduction of Blood Glucose Levels:
Lowers both fasting and postprandial glucose levels without significantly increasing the risk of hypoglycemia when used alone.
Beneficial Effects on Lipid Profile:
Pioglitazone may improve HDL cholesterol and reduce triglyceride levels, providing additional cardiovascular benefits.
Pidus Tablet 15 mg is indicated for:
Management of type 2 diabetes mellitus in adults
As monotherapy in patients who cannot tolerate other antidiabetic medications
As combination therapy with metformin, sulfonylureas, or insulin to improve glycemic control
Patients who require long-term improvement in insulin sensitivity
Adults: The usual starting dose is 15 mg once daily, taken with or without food.
Dosage may be adjusted based on glycemic response and tolerance, typically up to 30–45 mg per day as directed by a physician.
Regular blood glucose monitoring is recommended to assess efficacy.
Maintain dietary and lifestyle modifications alongside medication for optimal results.
Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.
Use caution in patients with heart failure, liver impairment, or a history of bladder cancer.
May cause fluid retention, weight gain, or edema; monitor for signs of congestive heart failure.
Pregnant and breastfeeding women should use only under medical supervision.
Regular liver function tests are advised during therapy.
Pidus Tablet is generally well-tolerated. Common side effects may include:
Weight gain or fluid retention
Mild edema
Headache or dizziness
Rare: hepatotoxicity, hypoglycemia (especially with combination therapy), or heart failure exacerbation
Patients should report unusual swelling, shortness of breath, or jaundice immediately.
Store below 30°C in a cool, dry place, protected from light. Keep out of reach of children.
Pidus Tablet 15 mg is an effective oral therapy for improving insulin sensitivity, lowering blood glucose levels, and supporting long-term glycemic control in adults with type 2 diabetes mellitus.
Login Or Registerto submit your questions to seller
No none asked to seller yet